Literature DB >> 16271916

Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.

Daniel Staub1, Nils Jonas, Michael J Zellweger, Charly Nusbaumer, Damian Wild, Matthias E Pfisterer, Jan Mueller-Brand, André P Perruchoud, Christian Mueller.   

Abstract

PURPOSE: To evaluate the utility of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels to detect myocardial ischemia.
METHODS: We conducted a prospective observational study in 260 consecutive patients with suspected myocardial ischemia referred for rest/ergometry myocardial perfusion single-photon emission computed tomography. Levels of NT-proBNP were determined before and immediately after symptom-limited bicycle ergometry.
RESULTS: Inducible myocardial ischemia on perfusion images was detected in 129 patients (49.6%). Baseline NT-proBNP and exercise induced increase in NT-proBNP (DeltaNT-proBNP) were significantly higher in patients with myocardial ischemia (median baseline NT-proBNP 155 pg/mL vs 91 pg/mL, P <.001; DeltaNT-proBNP 15 pg/mL vs 7 pg/mL, P = .002). Compared with patients in the lowest DeltaNT-proBNP quartile, those in the highest quartile of DeltaNT-proBNP had three times the risk of inducible ischemia (relative risk, 2.9; 95% confidence interval, 1.4 to 6.0; P = .003). Overall, the accuracy of baseline NT-proBNP and DeltaNT-proBNP in the detection of myocardial ischemia were similar to that of the exercise electrocardiogram (ECG). Combining exercise ECG and baseline NT-proBNP or DeltaNT-proBNP slightly increased the accuracy of exercise ECG only.
CONCLUSION: The NT-proBNP level at rest as well as DeltaNT-proBNP during exercise stress testing is associated with inducible myocardial ischemia. NT-proBNP levels may have incremental value in the diagnosis of myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271916     DOI: 10.1016/j.amjmed.2005.05.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Hypoxia regulates the natriuretic peptide system.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-07

2.  The never-ending story of cardiac biomarkers: A further step toward a very early detection of ischemic patients?

Authors:  Claudio Marcassa
Journal:  J Nucl Cardiol       Date:  2018-03-06       Impact factor: 5.952

3.  Biomarkers after risk stratification in acute chest pain (from the BRIC Study).

Authors:  Shiny Mathewkutty; Sanjum S Sethi; Ashish Aneja; Kshitij Shah; Rupa L Iyengar; Luke Hermann; Sayyar Khakimov; Louai Razzouk; Ricardo Esquitin; Rajesh Vedanthan; Terrie-Ann Benjamin; Marie Grace; Rosane Nisenbaum; Krishnan Ramanathan; Lakshmi Ramanathan; James Chesebro; Michael E Farkouh
Journal:  Am J Cardiol       Date:  2012-12-06       Impact factor: 2.778

4.  N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.

Authors:  Harsimran S Singh; Kirsten Bibbins-Domingo; Sadia Ali; Alan H B Wu; Nelson B Schiller; Mary A Whooley
Journal:  Clin Cardiol       Date:  2009-08       Impact factor: 2.882

Review 5.  Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation.

Authors:  Mirthe Dekker; Farahnaz Waissi; Nathalie Timmerman; Max J M Silvis; Leo Timmers; Dominique P V de Kleijn
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

6.  Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.

Authors:  Henrik Hultkvist; Eva Nylander; Éva Tamás; Rolf Svedjeholm; Jan Engvall; Jonas Holm; Eva Maret; Farkas Vánky
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

Review 7.  Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.

Authors:  Brian Kerr; Lisa Brandon
Journal:  Int J Cardiol Heart Vasc       Date:  2022-10-10

8.  NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia.

Authors:  Jacques De Greef; Maryke Funk; William J H Vermaak; Nalini S Perumal; Carlos D Libhaber; Mboyo-Di-Tamba Vangu
Journal:  Cardiovasc J Afr       Date:  2008 Sep-Oct       Impact factor: 1.167

9.  Does dipyridamole-induced ischaemia affect NT-proBNP secretion?

Authors:  Jacques De Greef; Radha Govender; William Vermaak; Nalini Perumal; Elena Libhaber; Mboyo-Di-Tamba Vangu
Journal:  Cardiovasc J Afr       Date:  2007 Nov-Dec       Impact factor: 1.167

10.  Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.

Authors:  Alexander T Limkakeng; J Clancy Leahy; S Michelle Griffin; Yuliya Lokhnygina; Elias Jaffa; Robert H Christenson; L Kristin Newby
Journal:  Open Heart       Date:  2018-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.